The significance of this finding was unexpected and difficult to interpret, and study authors concluded that additional work was needed to elucidate whether CD39 could be implicated in the pathogenesis of PAH or as a compensatory response. The gene discussed is ENTPD1; the disease is pulmonary arterial hypertension.